Brodszky Valentin
Brodszky Valentin
E-mail megerősítve itt: uni-corvinus.hu - Kezdőlap
Hivatkozott rá
Hivatkozott rá
The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres
S Simoens, G Dunselman, C Dirksen, L Hummelshoj, A Bokor, I Brandes, ...
Human reproduction 27 (5), 1292-1299, 2012
The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey
AA De Graaff, TM D'hooghe, GAJ Dunselman, CD Dirksen, L Hummelshoj, ...
Human reproduction 28 (10), 2677-2685, 2013
Alopecia areata and health‐related quality of life: a systematic review and meta‐analysis
F Rencz, L Gulácsi, M Péntek, N Wikonkál, P Baji, V Brodszky
British journal of dermatology 175 (3), 561-571, 2016
Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries
V Brodszky, P Baji, O Balogh, M Péntek
The European Journal of Health Economics 15, 65-71, 2014
EQ-5D in central and Eastern Europe: 2000–2015
F Rencz, L Gulácsi, M Drummond, D Golicki, V Prevolnik Rupel, J Simon, ...
Quality of Life Research 25, 2693-2710, 2016
Biosimilars for the management of rheumatoid arthritis: economic considerations
L Gulacsi, V Brodszky, P Baji, HU Kim, SY Kim, YY Cho, M Pentek
Expert review of clinical immunology 11 (sup1), 43-52, 2015
Epidemiology of osteoporosis related fractures in Hungary from the nationwide health insurance database, 1999–2003
M Pentek, C Horváth, I Boncz, Z Falusi, E Tóth, A Sebestyen, I Májer, ...
Osteoporosis international 19, 243-249, 2008
Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary
E Herédi, F Rencz, O Balogh, L Gulácsi, K Herszényi, P Holló, H Jókai, ...
The European Journal of Health Economics 15, 111-119, 2014
A budget impact model for biosimilar infliximab in Crohn’s disease in Bulgaria, the Czech Republic, Hungary, Poland, Romania, and Slovakia
V Brodszky, F Rencz, M Péntek, P Baji, PL Lakatos, L Gulácsi
Expert review of pharmacoeconomics & outcomes research 16 (1), 119-125, 2016
Adherence to biologic DMARD therapies in rheumatoid arthritis
T Koncz, M Pentek, V Brodszky, K Ersek, E Orlewska, L Gulacsi
Expert opinion on biological therapy 10 (9), 1367-1378, 2010
The rituximab biosimilar CT-P10 in rheumatology and cancer: a budget impact analysis in 28 European countries
L Gulácsi, V Brodszky, P Baji, F Rencz, M Péntek
Advances in therapy 34, 1128-1144, 2017
Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe
A Angelis, P Kanavos, J López-Bastida, R Linertová, J Oliva-Moreno, ...
The European Journal of Health Economics 17, 31-42, 2016
Cost-of-illness of patients with systemic sclerosis in a tertiary care centre
T Minier, M Péntek, V Brodszky, A Ecseki, K Kárpáti, A Polgar, L Czirjak, ...
Rheumatology 49 (10), 1920-1928, 2010
Parallel valuation of the EQ-5D-3L and EQ-5D-5L by time trade-off in Hungary
F Rencz, V Brodszky, L Gulácsi, D Golicki, G Ruzsa, AS Pickard, EH Law, ...
Value in Health 23 (9), 1235-1245, 2020
Disease burden of psoriatic arthritis compared to rheumatoid arthritis, Hungarian experiment
V Brodszky, P Bálint, P Géher, L Hodinka, G Horváth, É Koó, M Péntek, ...
Rheumatology international 30, 199-205, 2009
Health status and quality of life in patients with psoriasis: an Iranian cross-sectional survey
M Moradi, F Rencz, V Brodszky, A Moradi, O Balogh, L Gulácsi
Archives of Iranian medicine 18 (3), 0-0, 2015
Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a …
V Brodszky, M Péntek, PV Bálint, P Géher, O Hajdu, L Hodinka, G Horvath, ...
Scandinavian journal of rheumatology 39 (4), 303-309, 2010
Proposal of a new scoring formula for the Dermatology Life Quality Index in psoriasis
F Rencz, L Gulácsi, M Péntek, AK Poór, M Sárdy, P Holló, A Szegedi, ...
British Journal of Dermatology 179 (5), 1102-1108, 2018
Use of biologics for psoriasis in Central and Eastern European countries
F Rencz, L Kemény, JZ Gajdácsi, W Owczarek, P Arenberger, GS Tiplica, ...
Journal of the European Academy of Dermatology and Venereology 29 (11), 2222 …, 2015
A detailed analysis of ‘not relevant’responses on the DLQI in psoriasis: potential biases in treatment decisions
F Rencz, AK Poór, M Péntek, P Holló, S Kárpáti, L Gulácsi, A Szegedi, ...
Journal of the European Academy of Dermatology and Venereology 32 (5), 783-790, 2018
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20